Key result
Treatment of hyperglycemia with insulin protected against inflammation and improved cardiac function in a rat model of LPS-induced systemic inflammation.
Why the study?
Does insulin therapy improve cardiac function and reduce inflammation in a rat model of LPS-induced systemic inflammation with hyperglycemia?
Does insulin therapy improve cardiac function and reduce inflammation in a rat model of LPS-induced systemic inflammation with hyperglycemia?
Answers are grounded in this paper and cite their sources.
Insulin therapy protects against inflammation and cardiac dysfunction in a preclinical model of LPS-induced systemic inflammation with hyperglycemia.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hagiwara et al. (2009) studied LPS-induced systemic inflammation. Insulin with glucose vs. Hyperglycemia without insulin was evaluated on Cardiac function (+dP/dtmax and -dP/dtmin) and inflammatory mediators. Treatment of hyperglycemia with insulin protected against inflammation and improved cardiac function in a rat model of LPS-induced systemic inflammation.
Synapse has enriched 10 related papers. Consider them for comparative context: